APA Zitierstil

Dessai, S. B., Chakraborty, S., Babu, T. V. S., Nayanar, S., Bhattacharjee, A., Jones, J., . . . Patil, V. M. (2016). Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin. South Asian J Cancer.

Chicago Zitierstil

Dessai, S. B., S. Chakraborty, T. V. S. Babu, S. Nayanar, A. Bhattacharjee, J. Jones, S. Balasubramanian, und Vijay M. Patil. "Tolerance of Weekly Metronomic Paclitaxel and Carboplatin As Neoadjuvant Chemotherapy in Advanced Ovarian Cancer Patients Who Are Unlikely to Tolerate 3 Weekly Paclitaxel and Carboplatin." South Asian J Cancer 2016.

MLA Zitierstil

Dessai, S. B., et al. "Tolerance of Weekly Metronomic Paclitaxel and Carboplatin As Neoadjuvant Chemotherapy in Advanced Ovarian Cancer Patients Who Are Unlikely to Tolerate 3 Weekly Paclitaxel and Carboplatin." South Asian J Cancer 2016.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.